Objective Peripheral edema is considered to be a
common and annoying adverse effect of calcium channel
blockers (CCBs). It has been thought to occur secondary to
arteriolar dilatation causing intracapillary hypertension and
fluid extravasation. We aimed to evaluate the incidence and
withdrawal rate of peripheral edema with CCBs.